DK185486D0 - Octapeptidderivater - Google Patents

Octapeptidderivater

Info

Publication number
DK185486D0
DK185486D0 DK185486A DK185486A DK185486D0 DK 185486 D0 DK185486 D0 DK 185486D0 DK 185486 A DK185486 A DK 185486A DK 185486 A DK185486 A DK 185486A DK 185486 D0 DK185486 D0 DK 185486D0
Authority
DK
Denmark
Prior art keywords
sub
trp
cys
ala
thr
Prior art date
Application number
DK185486A
Other languages
English (en)
Other versions
DK174920B1 (da
DK185486A (da
Inventor
Andrew V Schally
Ren Zhi Cai
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/727,105 external-priority patent/US4650787A/en
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of DK185486D0 publication Critical patent/DK185486D0/da
Publication of DK185486A publication Critical patent/DK185486A/da
Application granted granted Critical
Publication of DK174920B1 publication Critical patent/DK174920B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK198601854A 1985-04-25 1986-04-22 Octapeptidsomastatinanloger, fremgangsmåde til fremstilling deraf samt en farmaceutisk præparat DK174920B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/727,105 US4650787A (en) 1985-04-25 1985-04-25 Biologically active octapeptides
US72710585 1985-04-25
US84353986 1986-03-28
US06/843,539 US4725577A (en) 1985-04-25 1986-03-28 Biologically active lysine containing octapeptides

Publications (3)

Publication Number Publication Date
DK185486D0 true DK185486D0 (da) 1986-04-22
DK185486A DK185486A (da) 1986-10-26
DK174920B1 DK174920B1 (da) 2004-02-23

Family

ID=27111452

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198601854A DK174920B1 (da) 1985-04-25 1986-04-22 Octapeptidsomastatinanloger, fremgangsmåde til fremstilling deraf samt en farmaceutisk præparat

Country Status (10)

Country Link
US (1) US4725577A (da)
EP (1) EP0203031B1 (da)
AT (1) ATE78831T1 (da)
AU (1) AU600895B2 (da)
CA (1) CA1333646C (da)
DE (1) DE3686200T2 (da)
DK (1) DK174920B1 (da)
HK (1) HK68793A (da)
IE (1) IE59621B1 (da)
SG (1) SG57793G (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
DE3845000C2 (de) * 1987-07-10 1998-11-19 Novartis Ag Anwendung von Octreotid zur Behandlung von Brustkrebs
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
DK0457888T3 (da) * 1989-12-08 1996-08-12 Univ Tulane Octapeptidanaloger af somatostatin med threonin i 6-stillingen
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
EP0450480B1 (en) * 1990-04-06 1995-06-21 The Administrators of The Tulane Educational Fund Somatostatin Analogues
US5668254A (en) * 1990-05-11 1997-09-16 Romano Deghenghi D-2-alkyl-tryptophan and peptides containing same
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
US5872100A (en) * 1990-05-11 1999-02-16 Deghenghi; Romano Peptides containing D-2-Alkyl-Tryptophan
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
FR2701952B1 (fr) * 1993-02-22 1995-03-31 Adir Nouveaux dérivés cyclopeptidiques de l'angiopeptine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
SG48977A1 (en) 1993-06-23 1998-05-18 Diatide Inc Radiolabeled peptides
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US6100377A (en) * 1994-06-10 2000-08-08 The Trustees Of The University Of Pennsylvania Constrained peptides
AU700066B2 (en) * 1994-09-27 1998-12-17 Romano Deghenghi Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
US5770687A (en) * 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
IT1277391B1 (it) * 1995-07-28 1997-11-10 Romano Deghenghi Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita
JPH09328499A (ja) * 1996-02-20 1997-12-22 American Cyanamid Co 純粋なソマトスタチンアンタゴニストおよびその使用方法
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
US5972895A (en) * 1996-12-11 1999-10-26 A. Glenn Braswell Composition and method for increasing growth hormone levels
US5972893A (en) * 1997-05-06 1999-10-26 Cedars-Sinai Medical Center Method of treating hyperprolactinemia and prolactinomas
EP1332762A1 (en) * 1997-05-01 2003-08-06 Cedars-Sinai Medical Center Method of treating hyperprolactinemia and prolactinomas
EP0979098B1 (en) * 1997-05-01 2003-03-12 Cedars-Sinai Medical Center Method of treating hyperprolactinemia and prolactinomas
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
DE69816808T2 (de) * 1997-05-13 2004-04-15 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin agoniste zur reduzierung von körpergewicht
ES2216290T3 (es) * 1997-05-13 2004-10-16 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatina y agonistas de la somatostatina para el tratamiento de insensibilidad a la insulina y de sindrome x.
EP0981364B1 (en) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
DK1401863T3 (da) 2001-06-08 2009-05-25 Ipsen Pharma Kimære somatostatin-dopamin-analoge
JP4578470B2 (ja) 2003-04-22 2010-11-10 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ ソマトスタチンベクター
US20070111930A1 (en) * 2005-11-10 2007-05-17 Palle Venkata Raghavendra A Process for preparing vapreotide
US8691761B2 (en) 2006-10-16 2014-04-08 Jean E. F. Rivier Somatostatin receptor 2 antagonists
PL2076535T3 (pl) * 2006-10-16 2013-08-30 Salk Inst Biological Studies Antagoniści somatostatyny selektywni względem receptora (SSTR2)
EP2719392B1 (en) 2008-06-12 2019-07-24 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
JP5799397B2 (ja) 2008-06-12 2015-10-28 イプセン・バイオイノベーション・リミテッドＩｐｓｅｎ Ｂｉｏｉｎｎｏｖａｔｉｏｎ Ｌｉｍｉｔｅｄ 癌の抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
WO2014197938A1 (en) 2013-06-13 2014-12-18 Antisense Therapeutics Ltd Combination therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209426A (en) * 1979-05-29 1980-06-24 American Home Products Corporation Polypeptides related to somatostatin
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4443434A (en) * 1982-08-18 1984-04-17 American Home Products Corporation Antiulcer agent
CH655505B (da) * 1982-08-24 1986-04-30
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
US4440904A (en) * 1983-01-31 1984-04-03 American Home Products Corporation Nonapeptide anti-secretory agents
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体

Also Published As

Publication number Publication date
IE861004L (en) 1986-10-25
AU600895B2 (en) 1990-08-30
CA1333646C (en) 1994-12-20
ATE78831T1 (de) 1992-08-15
SG57793G (en) 1993-07-09
HK68793A (en) 1993-07-23
DK174920B1 (da) 2004-02-23
DE3686200D1 (de) 1992-09-03
IE59621B1 (en) 1994-03-09
AU5633886A (en) 1986-10-30
EP0203031A3 (en) 1988-09-21
DK185486A (da) 1986-10-26
EP0203031A2 (en) 1986-11-26
EP0203031B1 (en) 1992-07-29
DE3686200T2 (de) 1993-03-11
US4725577A (en) 1988-02-16

Similar Documents

Publication Publication Date Title
DK185486D0 (da) Octapeptidderivater
EP0142272B1 (en) Peptides and their use in therapy
EP0528312A3 (en) Cyclic peptides and use thereof
WO1998021237A3 (en) Peptide compounds useful for modulating FGF receptor activity
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
EP1077070A3 (en) Oral drug delivery compositions
CA2207078A1 (en) Insulin derivatives with increased zinc binding
AU559914B2 (en) Peptide compounds
CA2097192A1 (en) Bombesin antagonists
US7189692B2 (en) Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
MX9702275A (es) Compuestos polipectidicos que contienen d-2 alquiltriptofano capaces de promover la liberacion de hormona del crecimiento.
ES8701785A1 (es) Un procedimiento para preparar un peptido ciclico basico conactividad antagonista de v1-vasopresina y oxitocina
DE3751398T2 (de) Substrat-Peptide.
ES8701784A1 (es) Un procedimiento para preparar un peptido ciclico con acti- vidad antagonista de vasopresina
NZ335879A (en) Somatostatin antagonist peptides having a D-amino acid at the second residue
AU2002351536A1 (en) Analogs of human growth hormone-releasing hormone, their preparation and use
CA2257973A1 (en) T cell antigen receptor peptides
KR890009974A (ko) 신규 화합물들
EP0346068A3 (en) D-cys6 vasopressin antagonists
CA2216704A1 (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
GB1425099A (en) Psychopharmacologically active peptides
TH35998A (th) Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น
IT1276734B1 (it) Composti polipeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della

Legal Events

Date Code Title Description
PUP Patent expired